Studio LSD Limited — Statement of deviation(s) or variation(s) under Reg. 32

Studio LSD Limited has informed the stock exchanges about a deviation or variation in its business plans. This regulatory filing is made under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. The company has stated that the actual performance or execution of its project or business activities has varied from what was previously disclosed to the market.

This disclosure is a routine compliance requirement. It ensures that the company keeps investors updated on any changes to its original business roadmap. While the filing does not specify the exact nature of the deviation, it signals that the company's current operational status differs from its past projections. Investors should review the full regulatory filing to understand the specific reasons behind the variation.

Investors should monitor the company's subsequent announcements for clarity on the reasons for this deviation. It is important to assess whether this change is temporary or indicates a significant shift in the company's strategic direction. Keeping an eye on the company's future quarterly results will help determine if this variation has a material impact on its financial performance.